Profile data is unavailable for this security.
About the company
Beijing Succeeder Technology Inc is a China-based company mainly engaged in the research and development, production and sales of testing instruments, reagents and consumables in the field of thrombosis and hemostasis in vitro diagnosis. The Company provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, platelet aggregation, and supporting reagents and consumables. Its products include testing instruments, reagents and consumables, such as automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups and SAW blood rheology special cleaning. The Company operates its businesses within the domestic market and to overseas markets.
- Revenue in CNY (TTM)297.74m
- Net income in CNY112.75m
- Incorporated2003
- Employees296.00
- LocationBeijing Succeeder Technology IncNo. 19, Baili Street, Daxing DistrictBEIJING 102600ChinaCHN
- Phone+86 1 053855568
- Fax+86 1 053855570
- Websitehttp://www.succeeder.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Hotgen Biotech Co Ltd | 520.50m | -67.64m | 2.80bn | 1.04k | -- | 0.8585 | -- | 5.38 | -0.7349 | -0.7349 | 5.74 | 35.25 | 0.1484 | 2.20 | 5.85 | 502,410.60 | -2.13 | 29.65 | -2.22 | 34.70 | 46.98 | 56.08 | -14.33 | 32.26 | 8.95 | -- | 0.0026 | 41.92 | -84.78 | 23.67 | -97.10 | -10.67 | 57.98 | -- |
| Chemclin Diagnostics Co Ltd | 443.86m | 139.29m | 2.93bn | 731.00 | 21.00 | 2.09 | -- | 6.60 | 0.3476 | 0.3476 | 1.11 | 3.49 | 0.2491 | 1.00 | 16.34 | 607,195.30 | 7.82 | 11.01 | 8.73 | 12.32 | 74.89 | 74.19 | 31.38 | 31.07 | 5.16 | -- | 0.1515 | 36.64 | -4.28 | 4.00 | -3.44 | -- | 44.10 | -- |
| Nanjing Vishee Medical Technology Co Ltd | 422.21m | 112.74m | 2.96bn | 700.00 | 26.16 | 1.84 | -- | 7.01 | 1.18 | 1.18 | 4.42 | 16.83 | 0.2401 | 3.12 | 12.37 | 603,153.40 | 6.41 | 10.27 | 6.92 | 11.43 | 70.21 | 73.26 | 26.70 | 33.99 | 8.31 | -- | 0.0003 | 47.57 | 43.72 | 17.34 | 45.22 | 16.55 | 26.69 | -- |
| Beijing Succeeder Technology Inc | 297.74m | 112.75m | 3.03bn | 296.00 | 26.95 | 1.85 | -- | 10.18 | 1.06 | 1.06 | 2.80 | 15.41 | 0.1766 | 2.51 | 8.66 | 1,005,870.00 | 6.69 | 7.77 | 7.02 | 8.25 | 60.39 | 61.03 | 37.85 | 38.34 | 14.78 | -- | 0.00004 | 22.22 | 20.40 | 6.60 | 12.29 | 15.57 | 99.03 | -- |
| Cowealth Medical China Co Ltd | 970.41m | 29.67m | 3.04bn | 240.00 | 102.39 | 2.60 | -- | 3.13 | 0.0745 | 0.0745 | 2.44 | 2.93 | 0.6435 | 3.90 | 1.25 | 4,043,355.00 | 2.01 | 5.80 | 2.59 | 8.09 | 19.62 | 20.74 | 3.13 | 6.14 | 3.65 | -- | 0.0829 | 23.89 | -14.62 | 3.85 | -42.96 | -6.75 | 32.85 | -- |
| Hangzhou Biotest Biotech Co Ltd | 518.65m | 104.29m | 3.21bn | 629.00 | 30.40 | 1.35 | -- | 6.19 | 0.9897 | 0.9897 | 4.94 | 22.27 | 0.204 | 2.61 | 6.85 | 824,563.60 | 4.01 | 29.45 | 4.23 | 33.30 | 52.42 | 56.83 | 19.64 | 41.59 | 12.53 | -- | 0.0003 | 29.32 | -76.75 | 19.65 | -86.22 | 41.33 | 34.82 | -- |
| Shanghai Kindly Enterprise Dev Gp Co Ltd | 2.28bn | 209.26m | 3.40bn | 4.23k | 16.06 | 1.36 | -- | 1.49 | 0.4796 | 0.4796 | 5.24 | 5.68 | 0.5585 | 3.89 | 2.41 | 540,095.70 | 5.79 | 8.09 | 9.27 | 16.09 | 30.45 | 36.01 | 10.37 | 12.53 | 1.25 | -- | 0.1931 | 26.55 | -21.36 | 11.08 | -25.92 | 9.44 | 4.85 | 1.30 |
| Shanghai General Hthy Info & Tech Co Ltd | 261.57m | 18.00m | 3.40bn | 355.00 | 188.93 | 3.18 | -- | 13.00 | 0.1324 | 0.1324 | 1.92 | 7.88 | 0.1908 | 1.16 | 0.5944 | 736,806.40 | 1.03 | 11.22 | 1.32 | 14.13 | 61.95 | 53.64 | 5.42 | 30.54 | 2.58 | -- | 0.1216 | 14.00 | -4.59 | 3.70 | -48.13 | -4.27 | 9.32 | -- |
Data as of Sep 13 2024. Currency figures normalised to Beijing Succeeder Technology Inc's reporting currency: Chinese Yuan Renminbi CNY
5.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2024 | 1.12m | 1.76% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 652.07k | 1.02% |
| China Life AMP Asset Management Co., Ltd.as of 30 Jun 2024 | 429.91k | 0.68% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2024 | 307.10k | 0.48% |
| Chang Xin Asset Management Co., Ltd.as of 30 Jun 2024 | 227.60k | 0.36% |
| JX Asset Management Co.,Ltdas of 30 Jun 2024 | 226.69k | 0.36% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2024 | 174.35k | 0.27% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 170.70k | 0.27% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2024 | 142.00k | 0.22% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024 | 99.36k | 0.16% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
